# Weiguang Biological

Latest news and articles about Weiguang Biological

Total: 2 articles found

Close-up of a hand holding a blood sample vial on blue background, representing COVID-19 testing.

Closing the Treatment Gap: Weiguang Biological Advances Hemophilia B Candidate in China

Weiguang Biological has received regulatory approval to begin clinical trials for Human Coagulation Factor IX, targeting Hemophilia B. This development marks a significant step in China's domestic rare disease treatment capabilities, though the company warns of the long-term risks inherent in drug development.

NeTe2026年6月1日 09:08

#Weiguang Biological#Hemophilia B#NMPA

Close-up of bacteria and crystal formations under a microscope, displaying intricate patterns.

Health

Weiguang Bio Advances Patient-Centric Care with Subcutaneous Immunoglobulin Trial Approval

Weiguang Biological has received NMPA approval to begin clinical trials for a subcutaneous human immunoglobulin injection. The therapy targets primary immunodeficiency diseases and represents a shift toward home-based, patient-friendly administration in the Chinese plasma market.

NeTe2026年3月24日 10:07

#Weiguang Biological#NMPA#Immunoglobulin